A detailed history of Natixis Advisors, L.P. transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Natixis Advisors, L.P. holds 63,651 shares of ZBH stock, worth $6.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
63,651
Previous 51,049 24.69%
Holding current value
$6.9 Million
Previous $5.54 Million 24.03%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$104.47 - $116.17 $1.32 Million - $1.46 Million
12,602 Added 24.69%
63,651 $6.87 Million
Q2 2024

Aug 01, 2024

SELL
$106.25 - $130.01 $1.67 Million - $2.04 Million
-15,673 Reduced 23.49%
51,049 $5.54 Million
Q1 2024

Apr 25, 2024

SELL
$119.98 - $132.61 $10.1 Million - $11.2 Million
-84,103 Reduced 55.76%
66,722 $8.81 Million
Q4 2023

Feb 06, 2024

BUY
$102.72 - $121.7 $637,274 - $755,026
6,204 Added 4.29%
150,825 $18.4 Million
Q3 2023

Nov 13, 2023

SELL
$110.76 - $143.18 $6.99 Million - $9.03 Million
-63,101 Reduced 30.38%
144,621 $16.2 Million
Q2 2023

Aug 15, 2023

BUY
$126.43 - $145.6 $3.49 Million - $4.02 Million
27,586 Added 15.31%
207,722 $30.2 Million
Q1 2023

May 11, 2023

BUY
$121.91 - $130.94 $2.26 Million - $2.43 Million
18,573 Added 11.5%
180,136 $23.3 Million
Q4 2022

Jan 27, 2023

BUY
$104.7 - $128.4 $4.36 Million - $5.35 Million
41,645 Added 34.73%
161,563 $20.6 Million
Q3 2022

Nov 14, 2022

BUY
$101.65 - $119.27 $1.18 Million - $1.38 Million
11,573 Added 10.68%
119,918 $12.5 Million
Q2 2022

Aug 12, 2022

SELL
$102.23 - $133.85 $6.34 Million - $8.3 Million
-62,013 Reduced 36.4%
108,345 $11.4 Million
Q1 2022

May 12, 2022

BUY
$108.42 - $129.58 $3.72 Million - $4.44 Million
34,275 Added 25.19%
170,358 $21.8 Million
Q4 2021

Feb 08, 2022

SELL
$115.43 - $146.63 $1.51 Million - $1.92 Million
-13,107 Reduced 8.79%
136,083 $17.3 Million
Q3 2021

Nov 15, 2021

SELL
$136.35 - $158.76 $2 Million - $2.32 Million
-14,641 Reduced 8.94%
149,190 $21.8 Million
Q2 2021

Aug 12, 2021

BUY
$152.95 - $173.41 $7,341 - $8,323
48 Added 0.03%
163,831 $26.3 Million
Q1 2021

May 05, 2021

BUY
$148.16 - $159.71 $2.79 Million - $3 Million
18,815 Added 12.98%
163,783 $26.2 Million
Q4 2020

Feb 12, 2021

BUY
$128.25 - $151.41 $2.84 Million - $3.36 Million
22,164 Added 18.05%
144,968 $22.3 Million
Q3 2020

Nov 12, 2020

SELL
$113.59 - $141.68 $932,914 - $1.16 Million
-8,213 Reduced 6.27%
122,804 $16.7 Million
Q2 2020

Aug 11, 2020

BUY
$87.02 - $133.4 $907,444 - $1.39 Million
10,428 Added 8.65%
131,017 $15.6 Million
Q1 2020

Apr 27, 2020

BUY
$78.28 - $155.73 $946,718 - $1.88 Million
12,094 Added 11.15%
120,589 $12.2 Million
Q4 2019

Feb 10, 2020

BUY
$127.4 - $146.83 $476,221 - $548,850
3,738 Added 3.57%
108,495 $16.2 Million
Q3 2019

Nov 12, 2019

BUY
$113.33 - $138.46 $1.4 Million - $1.71 Million
12,384 Added 13.41%
104,757 $14.4 Million
Q2 2019

Aug 12, 2019

BUY
$108.87 - $125.09 $1.34 Million - $1.54 Million
12,332 Added 15.41%
92,373 $10.9 Million
Q1 2019

May 15, 2019

SELL
$97.5 - $125.79 $422,565 - $545,173
-4,334 Reduced 5.14%
80,041 $10.2 Million
Q4 2018

Feb 13, 2019

SELL
$94.4 - $126.76 $310,198 - $416,533
-3,286 Reduced 3.75%
84,375 $8.75 Million
Q3 2018

Nov 13, 2018

BUY
$108.41 - $127.64 $2.57 Million - $3.02 Million
23,695 Added 37.04%
87,661 $11.5 Million
Q2 2018

Aug 14, 2018

BUY
$102.12 - $114.04 $1.17 Million - $1.3 Million
11,415 Added 21.72%
63,966 $0
Q1 2018

May 10, 2018

BUY
$104.31 - $124.46 $1.47 Million - $1.76 Million
14,104 Added 36.68%
52,551 $5.73 Million
Q4 2017

Feb 14, 2018

BUY
$105.55 - $120.83 $281,185 - $321,891
2,664 Added 7.44%
38,447 $4.64 Million
Q3 2017

Nov 14, 2017

BUY
$106.92 - $117.79 $3.83 Million - $4.21 Million
35,783
35,783 $4.19 Million

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $22.7B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Natixis Advisors, L.P. Portfolio

Follow Natixis Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.